BACKGROUND: Systematic information retrieval generally requires a two-step selection process for studies, which is conducted by two persons independently of one another (double-screening approach). To increase efficiency, two methods seem promising, which will be tested in the planned study: the use of text mining to prioritize search results as well as the involvement of only one person in the study selection process (single-screening approach). The aim of the present study is to examine the following questions related to the process of study selection: Can the use of the Rayyan or EPPI Reviewer tools to prioritize the results of study selection increase efficiency? How accurately does a single-screening approach identify relevant studies? Which advantages or disadvantages (e.g., shortened screening time or increase in the number of full texts ordered) does a single-screening versus a double-screening approach have? METHODS: Our study is a prospective analysis of study selection processes based on benefit assessments of drug and non-drug interventions. It consists of two parts: firstly, the evaluation of a single-screening approach based on a sample size calculation (11 study selection processes, including 33 single screenings) and involving different screening tools and, secondly, the evaluation of the conventional double-screening approach based on five conventional study selection processes. In addition, the advantages and disadvantages of the single-screening versus the double-screening approach with regard to the outcomes "number of full texts ordered" and "time required for study selection" are analyzed. The previous work experience of the screeners is considered as a potential effect modifier. DISCUSSION: No study comparing the features of prioritization tools is currently available. Our study can thus contribute to filling this evidence gap. This study is also the first to investigate a range of questions surrounding the screening process and to include an a priori sample size calculation, thus enabling statistical conclusions. In addition, the impact of missing studies on the conclusion of a benefit assessment is calculated. SYSTEMATIC REVIEW REGISTRATION: Not applicable.
